Mr Rick Legleiter, Adherium Chief Executive Officer, commented, “Purchase orders are in house with a fast growing pipeline for our sensors with expanded data capabilities. This latest market release expands the portfolio by adding more inhalers covered with physiological parameter capabilities. I am excited for patients and for commercial focus with our business partners.”
Yeah thats great Rick, but when are you going to project to us some serious reveneu growth, show us the money already... all these announcments but nothing hearty to them relating to potential revenue..
Surely you can give us some real projection... WE need multi millions to hit the back to get this bloody SP moving after all this time..
The Market just isn't excited because we have been hearing the same ole news over and over... time to show us the Money man, show me the money..
![]()
- Forums
- ASX - By Stock
- ADR
- Ann: Production & market release of new, next generation sensors
ADR
adherium limited
Add to My Watchlist
0.00%
!
0.5¢

Ann: Production & market release of new, next generation sensors, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.492M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1299973 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 1155292 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1299973 | 0.005 |
18 | 10901874 | 0.004 |
7 | 4503579 | 0.003 |
4 | 10050000 | 0.002 |
5 | 25600000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 1155292 | 4 |
0.007 | 287000 | 2 |
0.008 | 2500000 | 1 |
0.009 | 807118 | 2 |
0.010 | 625000 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
ADR (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online